← Eichor
Condition: Msi L Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Msi L

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
Phase 2 · 1 location(s) · Zhejiang University · NCT05731726PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
Phase 2 · 11 location(s) · Biotheus Inc. · NCT07133750A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in
Phase 1 · 10 location(s) · Cartography Biosciences · NCT07321106
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.